Individuals who did not use semaglutide were included for comparison
Iodine and tyrosine make T4, supported by iron, selenium , and vitamin A, B2, B3, B6, and C
Luciana Agoglia, Maria Chiara Chindamo, Cristiane Villela-Nogueira World Journal of Hepatology .2025;[Epub] CrossRef Evaluating the RESET care program: Advancing towards scalable and effective healthcare solutions for metabolic dysfunction-associated liver disease Mariana M Ramrez-Meja, Froylan D Martnez-Snchez, Jacqueline Crdova-Gallardo, Nahum Mndez-Snchez World Journal of Hepatology .2025;[Epub] CrossRef Association between glucose time-in-range and the severity of metabolic dysfunction-associated steatotic liver disease in Chinese adults with type 2 diabetes mellitus Chun-Hua Wang, Xuan-Yao Ji, Nian Ji, Qing-Feng Yan, Hong-Qing Xu, Xue-Qin Wang, Xiang-Fan Chen, Chun-Feng Lu BMC Endocrine Disorders .2025;[Epub] CrossRef Gut microbiota in patients with metabolic, dysfunction-associated steatotic liver disease Lissette Duarte, Fabien Magne, Martin Gotteland Current Opinion in Clinical Nutrition & Metabolic Care .2025
GLP-1 drugs were originally developed to treat type 2 diabetes, but several are now approved for chronic weight management: Wegovy (semaglutide), which is available as a pill or injection Zepbound (tirzepatide) injection Saxenda (liraglutide) injection Impact of Obesity on MS Progression Benefits of Weight Loss for People With MS Together, these findings suggest that weight loss may positively influence inflammation and symptoms relevant to MS, even though long-term effects on disease progression are still unclear, says Ali
